Are you a journalist? Please sign up here for our press releases
Subscribe to our monthly newsletter:
Cancer cell survival
19.11.2025
A new class of immune-activating molecules awakens anti-tumor immunity by targeting the tumor’s own defenses
14.11.2025
Brain & Behavior, Cancer, Viruses & Microorganisms, Molecular and Cell Biology, Disease, Drugs & Diagnostics
Weizmann researchers, together with Beilinson and Rambam physicians, reveal that diverse bacteria reside within brain tumors, potentially...
22.04.2025
Weizmann Institute researchers reveal how breast cancer cells enter a state of dormancy, remaining undetected for years, and why they suddenly...
10.04.2025
Researchers in Prof. Ido Amit’s lab identify a gene that reprograms macrophages into cancer-promoting cells — and show how to switch it off
27.03.2025
Researchers from Prof. Yardena Samuels’s lab manipulated cancer cells into making themselves visible to the immune system, creating a new...
04.11.2024
A newly developed antibody-based treatment for the most aggressive type of breast cancer might also be used to treat many other cancers
18.01.2024
Cancer, Immunology, Disease, Drugs & Diagnostics, Yeda Technology Transfer, Diagnostic Techniques and Drugs
A new kind of immunotherapy, based on crosstalk between different immune cells, could pave the way for innovative treatments of cancer and...
20.09.2023
Cancer alters cellular waste-processing machinery, helping it avoid detection by the immune system
08.08.2023
Weizmann Institute researchers identify a biomarker that may one day enable a subgroup of lung cancer patients to benefit from relapse-free...
08.02.2023
Weizmann Institute scientists have discovered how mutations in the BRCA genes, particularly prevalent among Ashkenazi Jews, lead to...
